Citations for
1DAG1, POMGNT1
Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N, Manya H, Yamada T, Tateno H, Kanagawa M, Kobayashi K, Akasaka-Manya K, Hirose Y, Mizuno M, Ikeguchi M, Toda T, Hirabayashi J, Senda T, Endo T, Kato R.
Proc Natl Acad Sci U S A 113(33):9280-5. doi: 10.1073/pnas.1525545113. Epub 2016 Aug 4. 2016
2AHNAK, DAG1
Giant scaffolding protein AHNAK1 interacts with β-dystroglycan and controls motility and mechanical properties of Schwann cells.
von Boxberg Y, Soares S, Féréol S, Fodil R, Bartolami S, Taxi J, Tricaud N, Nothias F.
Glia 62(9):1392-406. doi: 10.1002/glia.22685. Epub 2014 May 3. 2014
3DAG1, EOGT, POMGNT2
GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody.
Ogawa M, Nakamura N, Nakayama Y, Kurosaka A, Manya H, Kanagawa M, Endo T, Furukawa K, Okajima T.
Biochem Biophys Res Commun 440(1):88-93. doi: 10.1016/j.bbrc.2013.09.022. Epub 2013 Sep 13. 2013
4DAG1
Dystroglycan promotes filopodial formation and process branching in differentiating oligodendroglia.
Eyermann C, Czaplinski K, Colognato H.
J Neurochem. 120(6):928-47. 2012
5DAG1, LARGE
Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP.
Science 335(6064):93-6. doi: 10.1126/science.1214115. 2012
6B3GAT1, CHST10, DAG1
Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan.
Nakagawa N, Manya H, Toda T, Endo T, Oka S.
J Biol Chem 287(36):30823-32. doi: 10.1074/jbc.M112.363036. Epub 2012 Jul 16. 2012
7DAG1
Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway.
Sirour C, Hidalgo M, Bello V, Buisson N, Darribère T, Moreau N.
Mol Biol Cell. 22(16):2957-69. 2011
8DAG1
A dystroglycan mutation associated with limb-girdle muscular dystrophy.
Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltrán-Valero de Bernabé D, Gündeşli H, Willer T, Satz JS, Crawford RW, Burden SJ, Kunz S, Oldstone MB, Accardi A, Talim B, Muntoni F, Topaloğlu H, Dinçer P, Campbell KP.
N Engl J Med. 364(10):939-46. 2011
9DAG1
O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L, Campbell KP.
Science 327(5961):88-92.PMID: 20044576 2010
10DAG1, DEL3P21
Heterozygous deletion of a 2-Mb region including the dystroglycan gene in a patient with mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalities.
Frost AR, Böhm SV, Sewduth RN, Josifova D, Ogilvie CM, Izatt L, Roberts RG.
Eur J Hum Genet 18(7):852-5. Epub 2010 Mar 17.PMID: 20234391 2010
11AGRN, DAG1, EGR3
α-Dystroglycan is essential for the induction of Egr3, a transcription factor important in muscle spindle formation.
Williams S, Jacobson C.
Dev Neurobiol 70(7):498-507. 2010
12DAG1, LARGE
Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
de Bernabé DB, Inamori K, Yoshida-Moriguchi T, Weydert CJ, Harper HA, Willer T, Henry MD, Campbell KP.
J Biol Chem 284(17):11279-84. Epub 2009 Feb 24. 2009
13ANK2, ANK3, DAG1, DCTN4, DMD
An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.
Ayalon G, Davis JQ, Scotland PB, Bennett V.
Cell 135(7):1189-200. 2008
14DAG1, AGRN, MUSK
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin.
Scotton P, Bleckmann D, Stebler M, Sciandra F, Brancaccio A, Meier T, Stetefeld J, Ruegg MA.
J Biol Chem 281(48):36835-45. Epub 2006 Sep 29. 2006
15DAG1
Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan.
Yamamoto T, Kawaguchi M, Sakayori N, Muramatsu F, Morikawa S, Kato Y, Shibata N, Kobayashi M.
Neurosci Res 56(4):391-9. Epub 2006 Sep 26. 2006
16LARGE, DAG1
Molecular recognition by LARGE is essential for expression of functional dystroglycan.
Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, Muschler J, Dumanski JP, Michele DE, Oldstone MB, Campbell KP.
Cell 117(7):953-64. 2004
17DAG1, EZR
Ezrin-dependent regulation of the actin cytoskeleton by {beta}-dystroglycan.
Spence HJ, Chen YJ, Batchelor CL, Higginson JR, Suila H, Carpen O, Winder SJ.
Hum Mol Genet 13(15):1657-1668. Epub 2004 Jun 02. 2004
18ADGRG1, ALG5, APLP2, B3GNT3, BGN, C14orf1, CD151, CD99, CDH1, CDH32, CLPTM1, CNPY3, DAG1, DHX8, FXYD5, GDF15, HSP90B1, HSPA5, KRTCAP2, LAMA3, LMAN2, LYPD3, SPINT2, TEX261, TNFRSF12A
Identification of novel genes for secreted and membrane-anchored proteins in human keratinocytes.
Bonkobara M, Das A, Takao J, Cruz PD, Ariizumi K.
Br J Dermatol 148(4):654-64. 2003
19AGR3, DAG1, LYPD3
hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan.
Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA.
Br J Cancer 88(4):579-85. 2003
20DAG1, POMGNT1, WLKWS4
Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP.
Nature 418(6896):422-5. 2002
21DAG1
Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration.
Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP.
Cell. 110(5):639-48. 2002
22DAG1
Interactions of the rapsyn RING-H2 domain with dystroglycan.
Bartoli M, Ramarao MK, Cohen JB.
J Biol Chem. 276(27):24911-7. 2001
23CAV3, DAG1
Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.
Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP.
J Biol Chem 275(48):38048-58. 2000
24DAG1
The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle.
Bowe MA, Mendis DB, Fallon JR.
J Cell Biol. 148(4):801-10. 2000
25DAG1
Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.
Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, Petrucci TC.
Biochem Biophys Res Commun. 274(1):93-8. 2000
26DAG1
Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.
James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol M, Winder SJ.
J Cell Sci. 113 ( Pt 10):1717-26. 2000
27DAG1
The dynamics of dystroglycan.
Chamberlain J.
Nat Genet 23(3):256-8. No abstract available 1999
28DAG1
The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.
Rentschler S, Linn H, Deininger K, Bedford MT, Espanel X, Sudol M.
Biol Chem. 380(4):431-42. 1999
29DAG1
Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan.
Shimizu H, Hosokawa H, Ninomiya H, Miner JH, Masaki T.
J Biol Chem. 274(17):11995-2000. 1999
30DAG1
Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD, Moukhles H, Lindenbaum M, Carbonetto S.
Nat Genet. 23(3):338-42. 1999
31DAG1, LAMA2
Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae.
Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA.
Science 282(5396):2076-9. 1998
32DAG1
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.
Cao W, et al.
Science 282(5396):2079-81. 1998
33DAG1
A role for dystroglycan in basement membrane assembly.
Henry MD, et al.
Cell 95(6):859-70 1998
34DAG1
Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice.
Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP.
Hum Mol Genet 6(6):831-41. 1997
35DAG1, SCARMD4
A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave.
Lenk U, et al.
Hum Mol Genet 5 : 973-975. 1996
36DAG1
Rapsyn may function as a link between the acetylcholine receptor and the agrin-binding dystrophin-associated glycoprotein complex.
Apel ED, Roberds SL, Campbell KP, Merlie JP.
Neuron. 15(1):115-26. 1995
37DAG1, UTRN
A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering.
Campanelli JT, et al.
Cell 77 : 663-674. 1994
38DAG1
Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor.
Gee SH, et al.
Cell 77 : 675-686. 1994
39DAG1
Dystroglycan is a binding protein of laminin and merosin in peripheral nerve.
Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K.
FEBS Lett. 352(1):49-53. 1994
40DAG1
Single base polymorphism in the DAG1 gene detected by DGGE and mismatch PCR.
Ibraghimov-Beskrovnaya O, et al.
Hum Mol Genet 2 : 1983. 1993
41DAG1
Human dystroglycan : skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization.
Ibraghimov-Beskrovnaya O, et al.
Hum Mol Genet 2 : 1651-1657. 1993
42DAG1
Dystroglycan: tissue distribution, human muscle cDNA, genomic structure and chromosome mapping.
Ibraghimov-Beskrovnaya O, et al.
Am J Hum Genet 51 : A130. 1992
43DAG1, SGCA
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.
Ibraghimov-Beskrovnaya O, et al.
Nature 355 : 696-702. 1992